Ramosetron Hydrochloride 0.1 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 0.1 mg
Reference Brands: -
Category: Antiemetic
Ramosetron is a 5-HT3 antagonist used in Japan and Asia for nausea and vomiting from chemotherapy and, at a low dose (2.5–5 mcg), for irritable bowel syndrome with diarrhoea. Tablet and injection forms are marketed in Japan, Korea and India; reference brands include Nasea and Irribow. We quote from GMP-approved manufacturers and confirm document status, lead time and MOQ for each order.
Manufacture or export Ramosetron Hydrochloride? List it or send an offer →
Product Description:
Ramosetron is a selective serotonin 5-HT3 receptor antagonist used primarily to prevent and treat nausea and vomiting. It works by blocking serotonin receptors located in the gastrointestinal tract and the central nervous system. These receptors play a key role in triggering the vomiting reflex, especially during chemotherapy, surgery, or other medical treatments that stimulate serotonin release. By inhibiting this pathway, Ramosetron helps reduce the frequency and severity of nausea and vomiting and improves patient comfort during treatment.
In addition to its antiemetic use, Ramosetron is also prescribed for the management of diarrhea-predominant irritable bowel syndrome (IBS-D) in both men and women. It helps regulate intestinal movement and reduces symptoms such as frequent diarrhea, abdominal discomfort, and urgency. Due to its targeted action and longer receptor binding compared with some other drugs in the same class, Ramosetron is considered effective for controlling gastrointestinal symptoms with a relatively low dosing frequency.
Ramosetron is available in tablet and injectable forms in certain markets, and in India it is commonly marketed under the brand name Ibset. It is typically used under medical supervision to ensure appropriate dosing and patient safety.
Ramosetron Hydrochloride — third party manufacturing & bulk supply
Ramosetron Hydrochloride 0.1 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Ramosetron Hydrochloride is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ramosetron Hydrochloride listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Ramosetron Hydrochloride →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Ramosetron hydrochloride is used to prevent nausea and vomiting associated with cancer chemotherapy and surgery. It is also prescribed in some countries for the treatment of irritable bowel syndrome with diarrhea (IBS-D), particularly in patients who require targeted serotonin receptor blockade.
Ramosetron hydrochloride is a synthetic pharmaceutical compound that works by selectively blocking serotonin (5-HT3) receptors in the gastrointestinal tract and central nervous system, helping control vomiting reflexes and intestinal activity.
The most widely recognized trade name of Ramosetron hydrochloride is Nasea. Other trade names include Ibset, Ramoset, and Ramo depending on the country and manufacturer.
The original brand Nasea is associated with pharmaceutical development and marketing by Japanese pharmaceutical companies, with manufacturing and distribution handled by licensed pharmaceutical manufacturers in different regions.
The generic name is Ramosetron hydrochloride.
Common brand names include Nasea, Ibset, Ramoset, and Ramo.
Ramosetron hydrochloride is manufactured in GMP-approved pharmaceutical facilities located in countries such as Japan, India, and South Korea, depending on the company producing the product and the market where it is supplied.
0.1 mg orally or 0.3 mg intravenously once daily on chemotherapy days.
At much lower doses (2.5 mcg in women, 5 mcg in men, once daily), mainly in Japan.
Japan, Korea, India and other Asian markets (originator Astellas). It is not approved in the US or EU.
Related Products
Trimethobenzamide Hydrochloride
Strength:
200 mg , 200 mg/mL
Form: Capsules / Injection
Reference Brands: Tigan (USA)
View DetailsMeclizine Hydrochloride
Strength:
12.5 mg, 25 mg, 50 mg
Form: Tablets
Reference Brands: Antivert (USA), Bonine (USA)
View DetailsScopolamine (Hyoscine) Transdermal Patches
Strength:
1.5 mg
Form: Transdermal patch
Reference Brands: Transderm-Scop(US)
View DetailsDomperidone Tablets
Strength:
10 mg, 20 mg
Form: Tablet
Reference Brands: Motilium (EU)
View DetailsTropisetron Capsules
Strength:
5 mg
Form: Capsules
Reference Brands: Navoban(EU & Asia)
View DetailsNetupitant / Palonosetron Capsules
Strength:
300 mg netupitant and 0.5 mg palonosetron
Form: Capsules
Reference Brands: Akynzeo(US & EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit